Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innogenetics buys HIV diagnostic range from AVANT:

This article was originally published in Clinica

Executive Summary

Belgian company Innogenetics' North American subsidiary, based in Atlanta, Georgia, has bought AVANT Immunotherapeutics' TRAx product line for an undisclosed amount in cash and royalties. Innogenetics will have worldwide rights to sell, market and manufacture the line. The range includes the TRAx CD4, which is used to measure the number of CD4 cells in the blood of HIV sufferers to monitor disease progression and to determine treatment. The TRAx system is an enzyme-linked immunoassay that uses monoclonal antibodies for the measurement of specific T-lymphocytes in blood.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel